MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Biospace.com most likely does not offer any malicious content.
Secure connection support
HTTPS
Biospace.com provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Biospace.com most likely does not offer any adult content.
Popular pages
-
BioSpace: Biotech, Pharmaceutical and Clinical Research News
Drop In FDA Approvals (And New Administration) Rekindles Fears For The Future Of Pharma
-
Medtronic AccuRhythm AI technology receives 2023 MedTech Breakthrough Award as Best New Monitoring
Medtronic plc (NYSE: MDT) today announced its AccuRhythm™ AI algorithm technology is the winner of the 7th annual MedTech Breakthrough Awards program as the "Best New Monitoring Solution."
-
NervGen Pharma Reports Q1 2023 Results and Provides Operational Update Including Clinical Trials of
NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage,...
-
Cara Therapeutics Reports First Quarter 2023 Financial Results - BioSpace
Cara Therapeutics, Inc., a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, announced financial results and operati...
-
Abivax Announces its Ordinary and Extraordinary General Meeting of June 5, 2023, and the
Abivax (Euronext Paris: FR0012333284 - ABVX) informs its shareholders that its ordinary and extraordinary general meeting will be held on June 5, 2023, at 10:00 am (CEST), at the offices of Dechert (P...
-
StageZero to Issue Q1 2023 Financial Results After Market Closes May 15, 2023 - BioSpace
StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its first quarter 2023 operational results after the market closes on Monday May 15, 2023.